CG100649

DRUG5 trials

Sponsors

CrystalGenomics, Inc.

Conditions

HealthyLocalized Primary Osteoarthritis of HipLocalized Primary Osteoarthritis of KneeOsteoarthritisOsteoarthritis, HipOsteoarthritis, Knee

Phase 1

Phase I Study on Multiple Oral Dosing of CG100649

CompletedNCT01154790

CrystalGenomics, Inc.Healthy

Start: 2010-06-30End: 2011-01-31Updated: 2016-01-28

Trial for Studying Pharmacokinetic Effects of Ketoconazole on CG100649

CompletedNCT01154764

CrystalGenomics, Inc.Healthy

Start: 2009-10-31End: 2010-12-31Updated: 2024-01-03

Phase 2

Phase II Study of CG100649 for Primary Osteoarthritis in Male Subjects

CrystalGenomics, Inc.Osteoarthritis, Hip, Osteoarthritis, Knee

Start: 2007-10-31End: 2008-09-30Target: 240Updated: 2008-06-13

Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

CompletedNCT01341405

CrystalGenomics, Inc.Osteoarthritis

Start: 2011-04-30End: 2012-01-31Updated: 2023-02-09

Phase 3

Phase III Study of CG100649 in Osteoarthritis Patients

CompletedNCT01765296

CrystalGenomics, Inc.Localized Primary Osteoarthritis of Hip, Localized Primary Osteoarthritis of Knee

Start: 2013-03-31End: 2014-04-30Updated: 2023-02-15